| "Acuformis perennis" Prevot 1940| "Inflabilis barati" (sic) Prevot 1938| Acuformis perennis| ATCC 25782 [[Clostridium perenne (Prevot 1940) McClung and McCoy 1957 (Approved Lists 1980)]]| ATCC 27638| ATCC 27639 [[Clostridium paraperfringens Nakamura et al. 1970 (Approved Lists 1980)]]| BCRC 14541| CCRC 14541| CCRC:14541| CCUG 24033| CIP 104306| Clostridium barati| Clostridium baratii| Clostridium baratii corrig. (Prevot 1938) Holdeman and Moore 1970| Clostridium paraperfringens| Clostridium paraperfringens Nakamura et al. 1970 (Approved Lists 1980)| Clostridium perenne| Clostridium perenne (Prevot 1940) McClung and McCoy 1957 (Approved Lists 1980)| DSM 601| Inflabilis barati| JCM 1382 [[Clostridium paraperfringens Nakamura et al. 1970 (Approved Lists 1980)]]| JCM 1385| JCM 1409 [[Clostridium perenne (Prevot 1940) McClung and McCoy 1957 (Approved Lists 1980)]]| NCTC 10986 [[Clostridium paraperfringens Nakamura et al. 1970 (Approved Lists 1980)]]
Environmental Role: Flavobacterium aquatile and other members of the genus Flavobacterium are known for their diverse metabolic capabilities and their ability to degrade complex organic compounds in aquatic environments. They contribute to nutrient cycling, organic matter decomposition, and the maintenance of ecosystem balance in freshwater and marine habitats.
Biotechnological Applications: Some Flavobacterium species, including Flavobacterium aquatile, have been studied for their potential biotechnological applications, particularly in the fields of wastewater treatment, bioremediation, and aquaculture. They may have roles in the degradation of pollutants and the production of enzymes or bioactive compounds with industrial or environmental significance.
Rare Human Infections: While Flavobacterium aquatile is not considered a common human pathogen, there have been rare reports of infections in humans, typically associated with immunocompromised individuals or those with underlying medical conditions. In such cases, Flavobacterium aquatile infections may present as opportunistic infections, such as wound infections, bacteremia, or urinary tract infections.
Prevention: Preventive measures to minimize the risk of infections with Flavobacterium aquatile or other environmental bacteria include maintaining good hygiene practices, avoiding exposure to contaminated water sources, and implementing proper wound care and infection control measures, particularly in healthcare settings.
Other Sources for more information:
| R2 | Slope | Tax Name | Parent Chart |
|---|---|---|---|
| 0.1705072820186615 | 0.4362911581993103 | Clostridium gasigenes | Parent Taxa |
| 0.16670560836791992 | 0.39550867676734924 | Clostridium septicum | Parent Taxa |
| 0.15658792853355408 | 0.3734027147293091 | Clostridium isatidis | Parent Taxa |
| 0.14438191056251526 | 0.3738868832588196 | Jeotgalibaca arthritidis | Parent Taxa |
| 0.1281096190214157 | 0.33955785632133484 | Clostridium chauvoei | Parent Taxa |
| 0.12772269546985626 | 0.601120114326477 | Clostridium taeniosporum | Parent Taxa |
| 0.11975746601819992 | 0.32813629508018494 | Clostridium butyricum | Parent Taxa |
| 0.11810015141963959 | 0.33841007947921753 | Clostridium gelidum | Parent Taxa |
| 0.1149393692612648 | 0.3199004828929901 | Clostridium botulinum | Parent Taxa |
| R2 | Slope | Tax Name | Parent Chart |
|---|---|---|---|
| 0.1705072820186615 | 0.3908107876777649 | Clostridium gasigenes | Parent Taxa |
| 0.16670560836791992 | 0.42149674892425537 | Clostridium septicum | Parent Taxa |
| 0.15658792853355408 | 0.41935402154922485 | Clostridium isatidis | Parent Taxa |
| 0.14438191056251526 | 0.38616469502449036 | Jeotgalibaca arthritidis | Parent Taxa |
| 0.1281096190214157 | 0.37728360295295715 | Clostridium chauvoei | Parent Taxa |
| 0.11975746601819992 | 0.36496254801750183 | Clostridium butyricum | Parent Taxa |
| 0.11810015141963959 | 0.34898531436920166 | Clostridium gelidum | Parent Taxa |
| 0.1149393692612648 | 0.3592972755432129 | Clostridium botulinum | Parent Taxa |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]